Mercado de acciones de Merck aumenta en un 8.32% en una ronda de 6 días impulsada por el incremento del dividendo en un 6.2%

The share price rose to its highest level so far this month today, with an intraday gain of 1.82%. Merck & Co. (NYSE: MRK) extended its winning streak to six consecutive sessions, climbing 1.34% to close at $106.51, pushing its 6-day rally to 8.32%. The move followed a 6.2% dividend increase announced on December 15, raising the quarterly payout to $0.85 per share, which translates to a 3.2% yield and reinforces investor confidence in the company’s financial stability.

The dividend hike, coupled with Merck’s strong balance sheet, has attracted income-focused investors. The company’s payout ratio of 44.91% reflects a disciplined approach to capital allocation, balancing returns to shareholders with reinvestment. While prior earnings reports—such as $1.94 EPS in January—highlight long-term profitability, recent momentum is primarily driven by the dividend announcement. Technical indicators also support the upward trend, with the stock trading above both its 50-day ($95.05) and 200-day ($86.89) moving averages.

Merck’s conservative financial structure further underpins its appeal. A 14.07 P/E ratio, 1.66 current ratio, and 0.77 debt-to-equity ratio underscore its liquidity and low leverage, positioning it as a defensive play in a volatile market. However, analysts caution that near-term catalysts remain limited, with no major product launches or regulatory updates cited in recent disclosures. Institutional activity, including a future-dated sale by Highland Capital Management, holds no immediate relevance for the current rally. The stock’s performance underscores its role as a steady, dividend-driven asset in a sector favoring stability over rapid growth.